Back to Results
First PageMeta Content
Alcohols / Euphoriants / Ethers / Phenols / Buprenorphine / Drug Addiction Treatment Act / Opioid dependence / Methadone / Naloxone / Chemistry / Organic chemistry / Morphinans


Federal Register Notices > Scheduling Actions ­ 2002 > Schedules of Controlled Substances:  Rescheduling of Buprenorphine From Schedule V to Schedule III  Scheduling Actions ­ 2002  [Federal 
Add to Reading List

Document Date: 2013-10-29 08:28:54

Open Document

File Size: 432,78 KB

Share Result on Facebook

City

Preston / New York City / Bigelow / /

Company

Purdue Pharma / Reckitt Benckiser / Reckitt Benckiser Pharmaceuticals / Coleman / /

Country

France / United States / United Kingdom / Scotland / Ireland / /

Event

FDA Phase / Product Issues / Product Recall / /

Facility

Chemical Dependency Institute of Beth Israel Medical Center / /

IndustryTerm

entity buprenorphine product / sublingual products / potential addiction treatment products / hydrocodone products / entity product / sublingual aqueous alcohol solutions / case law / sublingual solution / pharmaceuticals / buprenorphine products / law offices / sublingual aqueous alcohol solution / combination product / buprenorphine containing products / aqueous solutions / pharmaceutical products / mono buprenorphine product / drug products / buprenorphine product / /

MedicalCondition

slow dissociation / less respiratory depression / disorientation / pain / heroin addiction / respiratory depression / miosis / /

Organization

International Narcotics Control Board / World Health Organization / Food and Drug Administration / American Academy of Addiction Psychiatry / DEPARTMENT OF JUSTICE Drug Enforcement Administration / ASAM's Medication Development Committee / California Society of Addiction Medicine / American Society of Addiction Medicine / Department of Justice / Board of Directors of AATOD / American Psychiatric Association / Chemical Dependency Institute / United Nations / College on Problems of Drug Dependence / Opioid Agonist Treatment Committee / American Association for the Treatment of Opioid Dependence / Beth Israel Medical Center / Department of Health and Human Services / Chair Committee for the Treatment of Opioid Dependence / /

Person

Frank Sapienza / /

/

Position

Chief / Drug and Chemical Evaluation Section / Director of the Edmond de Rothschild Foundation / President / Walker / Medical Director / Deputy Administrator / /

Product

Subutex / nalbuphine / naloxone / Suboxone / buprenorphine hydrochloride / Buprenex / V / Buprenex® / buprenorphine / /

SocialTag